Diagnostic potential of serum HSP90 beta for HNSCC and its therapeutic prognosis after local hyperthermia therapy.
The present pilot study aims to investigate the diagnostic and prognostic efficacy of serum HSP90 beta in Head and Neck Squamous Cell Carcinoma (HNSCC) patients subjected to localized hyperthermia therapy (HT). Serum levels of HSP90 beta were measured by ELISA and its diagnostic and prognostic effic...
Main Authors: | Neena G Shetake, Amit Kumar, Nagraj Huilgol, Badri N Pandey |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0281919 |
Similar Items
-
Hyperthermia therapy of cancer: Need for deeper biological insights for improved therapeutic outcome
by: Neena G Shetake, et al.
Published: (2019-01-01) -
Reimagining hyperthermia in oncology
by: Nagraj Huilgol
Published: (2018-01-01) -
Magnetic hyperthermia therapy: An emerging modality of cancer treatment in combination with radiotherapy
by: Neena Girish Shetake, et al.
Published: (2016-01-01) -
Functions and Therapeutic Potential of Extracellular Hsp60, Hsp70, and Hsp90 in Neuroinflammatory Disorders
by: Giusi Alberti, et al.
Published: (2021-01-01) -
Heat Shock Protein 90 (Hsp90) and Hsp70 as Potential Therapeutic Targets in Autoimmune Skin Diseases
by: Stefan Tukaj, et al.
Published: (2022-08-01)